Joint Chairman and CEO at #VNET bought 40,000 shares at 69p each. I don't hold.
#AZN Calquence combined with Venetoclax approved in US for treating Adults with Chronic Lymphocytic Leukaemia in a particular form.
Not much News again. All these Takeovers and changes of Listing Venue have really hollowed out the UK market.
#CNA hit by Gas Price but raised Dividend. Positive long-term statements. I hold a tiny amount I inherited and not particularly interested in holding it.
#CRE results read OK although clearly the environment is tougher. ShareScope showing fwd p/e 10.9 falling to 6.5 and fwd Divvy 6.6% each of next 2 years. Reinsurance is high risk but it's an interesting business. I don't hold.
#KEYS "Marginally ahead of current market expectations". Strong Update. ShareScope has fwd p/e 17.8 falling to 17.6 and fwd Divvy 3.9% each of next 2 years. With the 'beat' it looks good value. I hold #GTLY (which hopefully is also...
#BA. Results read well and market happy with them. SharePad has fwd p/e 27.3 falling to 24.2 and fwd Divvy 1.8% rising to 2%; it's getting quite a high rating but I'm happy to keep as my biggest position, as...
#INPP FY Results Thursday 26th March with an Investor Meet presentation at 4pm that day: